DSIP: What the Delta Sleep-Inducing Peptide Literature Actually Shows
For laboratory research use only. The compounds discussed here are sold strictly for in vitro research. They are not drugs, supplements or cosmetics and are not for human or animal use. This article summarizes published literature for reference and is not medical or usage advice.
Delta sleep inducing peptide, or DSIP, is one of those compounds that people have poked at for almost fifty years without ever pinning down a clean answer. It is a nine amino acid peptide, first pulled out of rabbit blood in the 1970s, and the honest version is this: its mechanism, its receptor, even its natural job, all still up in the air. That is exactly why we enjoy writing about it. So this piece sticks to what has genuinely been measured: the sequence, the stability, how it slips across membranes, and why decades of work have left us with more questions than answers.
Key findings
- DSIP is a nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu and a molecular weight near 849 [1][2].
- It was isolated by the Schoenenberger and Monnier group in Basel and named for the slow wave, delta frequency activity it enhanced after intraventricular infusion in rabbits [1].
- Despite being charged and hydrophilic, DSIP can cross biological membranes, a property tied to its solution conformation and beta turn structure [3].
- A 2006 review called the link between DSIP and sleep “poorly documented and still weak,” and no DSIP gene or receptor has been isolated [4].
Where DSIP came from
The origin story is specific and worth getting right, because a lot of secondhand writing mangles it. In 1977, Schoenenberger and Monnier reported a peptide isolated from rabbits that enhanced slow wave, delta frequency electroencephalogram activity after infusion into the brain ventricles. They named it delta sleep inducing peptide and published its sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu [1]. In that same paper they synthesized the peptide along with several fragments and analogues and tested all of them under double blind conditions in 58 rabbits. Only the full synthetic nonapeptide produced the delta and spindle enhancement [1].
That is a cleaner experiment than its reputation suggests. The trouble started afterward, when the effect proved hard to reproduce consistently and the molecule turned out to do a lot of unrelated things.
What it is at the molecular level
DSIP is tiny: nine residues, molecular weight around 849 [2]. Its sequence does not slot into any known peptide family, which is half the reason it has stayed both interesting and annoying to classify. Graf and Kastin, back in their 1984 review, flagged that DSIP like material turned up by radioimmunoassay not only in brain but in peripheral organs and in the plasma of several mammals, and that it seemed to nudge a whole grab bag of readouts: electrophysiological activity, neurotransmitter levels, circadian patterns, hormone concentrations [2]. When one little peptide looks like it touches that many systems at once, you are usually staring at either a very general role or a measurement artifact. The field never fully settled which.
Crossing membranes
One genuinely well characterized feature is how DSIP behaves at barriers. It is charged and water loving, which normally predicts poor membrane permeability, yet it crosses the blood brain barrier. Gray and colleagues used nuclear magnetic resonance, circular dichroism and infrared spectroscopy to study its solution shape and found it sits in a dynamic equilibrium between unordered and folded states, with residues 2 to 5 and 6 to 9 forming type I beta turns [3]. That folding is thought to underlie its unusual ability to slip across membranes.
In a Caco-2 intestinal cell model, though, the picture got messier. DSIP applied to the apical side was rapidly broken down, mostly to tryptophan, and even when the main degradation pathways were blocked, intact DSIP did not cross to the other side [5]. So a peptide that passes brain endothelium readily does not necessarily pass intestinal epithelium, a reminder that “membrane permeable” is always context specific.
Why the sleep story stayed unsettled
Here is the part the old marketing copy always skipped. In 2006, Kovalzon and Strekalova looked back at three decades of DSIP work and concluded the connection between DSIP and sleep “has never been further characterized” and remains weak, in large part because no one isolated a DSIP gene, a DSIP protein product, or a candidate receptor [4]. They even floated the idea that some other, DSIP like peptide might account for the immunoreactivity and activity attributed to DSIP itself. That is an extraordinary thing to still be saying thirty years after a compound is named, and it is the single most important fact to carry away from the literature.
Earlier reviews had already hinted at the problem. Graf and Kastin described a U shaped concentration response and effects scattered across many systems, the kind of profile that is hard to pin to a single mechanism [2].
Handling and characterization
As a short, degradation prone peptide, DSIP is kept lyophilized, cold and dry. Its identity is confirmed the same way other peptides are: high performance liquid chromatography to separate it from truncated byproducts and mass spectrometry to confirm that molecular weight near 849. Those analytical steps are what any purity statement rests on, and you can see how we document them on our certificates of analysis. If you want the broader context on how peptides are classified and named, our primer on peptides and polypeptides is a good starting point, and the neuropeptide overview places DSIP among its neighbors.
FAQ
What is the DSIP sequence?
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, a nine residue peptide with a molecular weight near 849 [1].
Does DSIP have a known receptor?
No. As of the most recent reviews, no DSIP gene, protein product, or receptor has been isolated, which is a major reason its biology stays unresolved [4].
Why is DSIP described as membrane permeable?
Its solution conformation, with beta turns in both halves of the molecule, lets it cross the blood brain barrier despite being charged and hydrophilic [3].
References
- Schoenenberger GA, Monnier M. Characterization of a delta-electroencephalogram (-sleep)-inducing peptide. Proc Natl Acad Sci U S A. 1977. PMID 265572.
- Graf MV, Kastin AJ. Delta-sleep-inducing peptide (DSIP): a review. Neurosci Biobehav Rev. 1984. PMID 6145137.
- Gray RA, Vander Velde DG, Burke CJ, et al. Delta-sleep-inducing peptide: solution conformational studies of a membrane-permeable peptide. Biochemistry. 1994. PMID 8312250.
- Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. J Neurochem. 2006. PMID 16539679.
- Augustijns PF, Borchardt RT. Transport and metabolism of delta sleep-inducing peptide in cultured human intestinal epithelial cell monolayers. Drug Metab Dispos. 1995. PMID 8689946.

USA-made peptides, third-party tested every batch, with the COA published for each lot.
